Some COVID vaccines may cause heavy menstrual bleeding, specialists at the European Medicines Agency (EMA) warned Friday, recommending that this be added to the list of potential side effects.
“Cases of heavy menstrual bleeding have been reported after the first, second, and booster doses of Comirnaty (Pfizer) and Spikevax (Moderna),” said a statement from the agency, citing its drugs safety committee.
Having reviewed the data, they concluded that “there is at least a reasonable possibility that the occurrence of heavy menstrual bleeding is causally associated with these vaccines”.
They thus recommended that this be added to the product information of the two mRNA COVID-19 vaccines.
“There is no evidence to suggest the menstrual disorders experienced by some people have any impact on reproduction and fertility,” the EMA statement added.
The safety committee also stressed that “the benefits of these vaccines greatly outweigh the risks”.
The instances of heavy menstrual bleeding have been monitored at both national and European level since the first reports appeared among vaccinated women.
France’s National Medicine Safety Agency (ANSM) started interviewing women about the issue in July, passing their findings to the EMA.
So far, however, researchers have not established a causal connection beyond any doubt.
The reported issues mainly concern changes to the length and intensity of the menstrual bleeding, which are sometimes more painful.
While in most cases the symptoms experienced were “not serious” and transitory, some women experienced the symptoms for up to six months, the ANSM reported.
The French agency is continuing to research the issue.
more recommended stories
Green tea extract may harm liver in people with certain genetic variations
Long-term use of high-dose green tea.
Study finds that experiences of daily stress decrease as people age
Stories about how daily stress can.
Researchers study relationship between epilepsy drug and Alzheimer’s disease
Researchers from an Indiana University School.
A new test quickly and easily detects scopolamine (devil’s breath) and MDPV (monkey dust) in saliva and drinks
According to recent studies, sexual assault.
Commonly used macular degeneration drug outperforms another at weaning patients off treatment at one year
A pilot, “look-back” study of information.
Antibiotics’ effect on the mycobiome found to vary from person to person
Treatment with antibiotics disrupts the balance.
Post-pandemic outbreak of drug-resistant fungus in Brazil stemming from abuse of medications and full ICUs
In Brazil, a group of researchers.
Excess oxygen during surgery linked to higher risk of organ damage
Giving patients excess levels of oxygen.
Research reveals how a potentially fatal COVID-19 complication damages lung tissue
Mechanisms involved in the rapid, severe.
Non-hormonal gel proves effective at helping mucus block sperm, with low risk of side effects
A new way to prevent pregnancy.